scholarly journals Opioid-Prescribing Guidelines for Common Surgical Procedures: An Expert Panel Consensus

2018 ◽  
Vol 227 (4) ◽  
pp. 411-418 ◽  
Author(s):  
Heidi N. Overton ◽  
Marie N. Hanna ◽  
William E. Bruhn ◽  
Susan Hutfless ◽  
Mark C. Bicket ◽  
...  
2020 ◽  
Vol 82 (3) ◽  
pp. 700-708
Author(s):  
Justin M. McLawhorn ◽  
Matthew P. Stephany ◽  
William E. Bruhn ◽  
Lauren D. Crow ◽  
Brett M. Coldiron ◽  
...  

2020 ◽  
Vol 8 (7_suppl6) ◽  
pp. 2325967120S0039
Author(s):  
Nikhil Mandava ◽  
Demetris Delos ◽  
Katherine Vadasdi ◽  
R. Greene ◽  
Marc Kowalsky ◽  
...  

Objectives: Opioid prescriptions following knee arthroscopy vary substantially, ranging from 15 to 60 opioid pills.[1-3] Expert panel guidelines recommend up to 30 pills for knee arthroscopy and 60 pills for anterior cruciate ligament reconstruction (ACLR) using an autograft; however, these recommendations are based on consensus rather than evidence.[4] Currently, orthopaedic surgeons do not possess any evidence driven guidelines for opioid prescriptions following knee arthroscopy or ACLR. The purpose of this study was to record patients’ postoperative opioid requirement to develop evidence driven prescription guidelines for knee arthroscopy and ACLR. Tepolt FA, Bido J, Burgess S, Micheli LJ, Kocher MS. Opioid Overprescription After Knee Arthroscopy and Related Surgery in Adolescents and Young Adults. Arthroscopy. 2018;34(12):3236-3243. Gardner V, Gazzaniga D, Shepard M, et al. Monitoring Postoperative Opioid Use Following Simple Arthroscopic Meniscectomy: A Performance-Improvement Strategy for Prescribing Recommendations and Community Safety. JB JS Open Access. 2018;3(4):e0033. Wojahn RD, Bogunovic L, Brophy RH, et al. Opioid Consumption After Knee Arthroscopy. J Bone Joint Surg Am. 2018;100(19):1629-1636. Stepan JG, Lovecchio FC, Premkumar A, et al. Development of an Institutional Opioid Prescriber Education Program and Opioid-Prescribing Guidelines: Impact on Prescribing Practices. J Bone Joint Surg Am. 2019;101(1):5-13. Methods: This prospective multicenter observational study enrolled 50 subjects undergoing outpatient knee arthroscopy for meniscal repair, meniscectomy, or ACLR. Opioid prescriptions, refills, and subject demographics were recorded. All patients followed the same perioperative, multimodal analgesic regimen (Table 1). Subjects were provided a pain journal to record visual analog scale (VAS) pain scores and opioid consumption for one week postoperatively. No changes were made to existing prescribing habits, postoperative physical rehabilitation, or surgical methodology. State databases were reviewed for additional opioid prescriptions. Results: Subjects, on average, consumed 2.5 opioid pills (range 0 to 14 pills) with a median consumption of 0.5 pills after knee arthroscopy. Eighty six percent of subjects (N = 43) consumed ≤ 5 opioid pills and 50% of subjects (N = 25) chose not to consume opioids postoperatively. Ninety two percent of subjects (N = 46) discontinued opioid consumption by the 3rd postoperative day. Subjects specifically undergoing ACLR (N = 18) consumed an average of 41 OME (Figure 1). Subjects consumed only 30% of opioids leaving 2,196 OME (approximately 293 oxycodone 5mg) available for possible distribution or misuse. Conclusion: This study demonstrates that current expert panels recommend an excess of opioids following knee arthroscopy. In contrast to these expert panel guidelines, we suggest a maximum of 5 and 15 oxycodone 5mg pills for knee arthroscopy and ACLR respectively. This evidence driven guideline will greatly assist orthopaedic surgeons in their effort to combat opioid overprescription. [Table: see text][Figure: see text]


2018 ◽  
Vol 227 (4) ◽  
pp. S196-S197
Author(s):  
Kathryn T. Anderson ◽  
Marisa A. Bartz-Kurycki ◽  
Dalya M. Ferguson ◽  
Akemi L. Kawaguchi ◽  
Mary T. Austin ◽  
...  

2019 ◽  
Vol 217 (4) ◽  
pp. 613-617 ◽  
Author(s):  
Tamar B. Nobel ◽  
Shruti Zaveri ◽  
Prerna Khetan ◽  
Celia M. Divino

2018 ◽  
Vol 100 (19) ◽  
pp. e127 ◽  
Author(s):  
Michael P. Gaspar ◽  
Emily M. Pflug ◽  
Alexander J. Adams ◽  
Sidney M. Jacoby ◽  
Eon K. Shin ◽  
...  

2020 ◽  
Vol 203 (1) ◽  
pp. 151-158 ◽  
Author(s):  
Kevin Koo ◽  
Farzana Faisal ◽  
Natasha Gupta ◽  
Alexa R. Meyer ◽  
Hiten D. Patel ◽  
...  

2019 ◽  
Vol 76 (18) ◽  
pp. 1403-1412 ◽  
Author(s):  
Mark C Bicket ◽  
Gabriel A Brat ◽  
Susan Hutfless ◽  
Christopher L Wu ◽  
Suzanne A Nesbit ◽  
...  

AbstractPurposeMillions of Americans who undergo surgical procedures receive opioid prescriptions as they return home. While some derive great benefit from these medicines, others experience adverse events, convert to chronic opioid use, or have unused medicines that serve as a reservoir for potential nonmedical use. Our aim was to investigate concepts and methods relevant to optimal opioid prescribing and pain treatment in the perioperative period.MethodsWe reviewed existing literature for trials on factors that influence opioid prescribing and optimization of pain treatment for surgical procedures and generated a conceptual framework to guide future quality, safety, and research efforts.ResultsOpioid prescribing and pain treatment after discharge from surgery broadly consist of 3 key interacting perspectives, including those of the patient, the perioperative team, and, serving in an essential role for all patients, the pharmacist. Systems-based factors, ranging from the organizational environment’s ability to provide multimodal analgesia and participation in enhanced recovery after surgery programs to other healthcare system and macro-level trends, shape these interactions and influence opioid-related safety outcomes.ConclusionsThe severity and persistence of the opioid crisis underscore the urgent need for interventions to improve postoperative prescription opioid use in the United States. Such interventions are likely to be most effective, with the fewest unintended consequences, if based on sound evidence and built on multidisciplinary efforts that include pharmacists, nurses, surgeons, anesthesiologists, and the patient. Future studies have the potential to identify the optimal amount to prescribe, improve patient-focused safety and quality outcomes, and help curb the oversupply of opioids that contributes to the most pressing public health crisis of our time.


Sign in / Sign up

Export Citation Format

Share Document